PI(4)K Inhibitor Could Prove Cure For Killer Diarrhoea

News   Jun 06, 2017 | Original Story from Novartis

 
A Cryptosporidium PI(4)K Inhibitor is a Drug Candidate for Cryptosporidiosis

Cryptosporidium parvum. Credit: EPA/H.D.A. Lindquist

 
 
 

RELATED ARTICLES

Medivir Outsources Compound Management to BioAscent

News

BioAscent is now managing 56,000 samples of Medivir's compound collection for their ongoing drug discovery activities.

READ MORE

Sugars in Human Mother’s Milk are Non-toxic Antibacterial Agents

News

Scientists have discovered that some of the carbohydrates in human milk not only possess antibacterial properties of their own but also enhance the effectiveness of the antibacterial proteins also present.

READ MORE

Lab Innovations Continues Partnership with the Royal Society of Chemistry

News

Lab Innovations, returns for its sixth year providing professionals with offers in a wide variety of sectors including pharmaceuticals.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE